EGFR and cancer: In contrast, transcriptional activation of extracellular organization, the PD-1 signaling pathway, and the PI3K/AKT signaling in cancer pathway positively correlated with increased tumor-stroma interactions and, by extension, EGFR TKI resistance (Figure 5B and Supplemental Figure 4).